Duke Antimicrobial Stewardship Outreach Network (DASON)
DASON Digest
The DASON Digest features engaging conversations with experts in infectious diseases and antimicrobial stewardship covering a variety of topics. New episodes of the Digest are published every other Friday. Subscribe to follow along with our latest content. For more information about DASON, please visit https://dason.medicine.duke.edu.
Be sure to visit the podcast's website and support the creator: pnc.st
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Ep.98 – Choosing Wisely: Antibiotic Decisions in Outpatient Community-Acquired Pneumonia 25.10.2024 19:05
Join Dr. Angelina Davis as she discusses a recent article in Clinical Infectious Diseases on differences in outpatient community-acquired pneumonia treatment regimens. the article reviewed in this episode can be found here: https://pubmed.ncbi.nlm.nih.gov/39442057/ For more information about DASON, please visit: https://dason.medicine.duke.edu/
Ep.97 – A Multicenter Retrospective Study Evaluating Intravenous to Oral Antibiotic Stepdown for Uncomplicated Streptococcal Bacteremia 11.10.2024 26:20
Episode Notes In this episode of the DASON Digest podcast, DASON Clinical Pharmacist Liaison Dr. Melissa Johnson reviews an article that compares the efficacy and safety of intravenous (IV) versus oral (PO) stepdown therapy for uncomplicated streptococcal bacteremia. The article can be found here: https://academic.oup.com/ofid/article/11/7/ofae361/7701251 For more information about DASON, please v...
Ep.96 – Update Alert! IDSA Resistant Gram-negative Guidance Version 4.0 27.09.2024 38:06
Episode Notes In this episode, Dr. Jeannette Bouchard and guest Dr. Emily Heil walk listeners through key updates to the IDSA Resistant Gram-negative Guidance and what may be most pertinent for our community partners. The materials reviewed today can be found here: https://www.idsociety.org/practice-guideline/amr-guidance/#UpdateHistory For more information about DASON, please visit: https://dason...
Waiting on a Culture: Impact of pharmacist-led microresult follow-up post-discharge 13.09.2024 18:51
Episode Notes In this episode, Dr. April Dyer discusses a recent article in Antimicrobial Stewardship and Hospital Epidemiology on how pharmacists can help with post-hospital discharge micro result review. The article reviewed in today's episode can be found here: https://www.cambridge.org/core/journals/antimicrobial-stewardship-and-healthcare-epidemiology/article/impact-of-pharmacistled-microbiol...
Ep.94 – Rethinking Daptomycin Dosing: New data on fixed dose daptomycin 30.08.2024 18:07
Episode Notes Join DASON Clinical Pharmacist Dr. Libby Dodds Ashley as she discusses a recent article in Pharmacotherapy on daptomycin dosing with one of the primary authors, Dr. Katie Olney. The article reviewed in this episode can be found here: https://pubmed.ncbi.nlm.nih.gov/39078247/ For more information about DASON, please visit: https://dason.medicine.duke.edu/
Ep.93 – Return of the Penicillin Allergy Label 20.08.2024 12:18
Episode Notes In this exciting episode, DASON Clinical Pharmacist Dr. April Dyer discusses a hot off the press article that follows up the results from the big PALACE trial that was published in 2023. The article reviewed in this episode can be found here: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2822413 For more information about DASON, please visit: https://dason.medicine.duk...
Ep.92 – Is One Better Than the Other? Analyzing surrogates for oral cephalosporin susceptibilities 02.08.2024 26:18
Episode Notes In this exciting episode, Dr. Jeannette Bouchard is joined by Drs. Katie Lambert and Catessa Howard to discuss their newly published brief report in OFID that helps shine a light on a common clinical issue, is cefazolin or ceftriaxone a better surrogate for third generation oral cephalosporins. The article reviewed in this episode can be found here: https://www.ncbi.nlm.nih.gov/pmc/a...
Is ID the Consult of Fear? 19.07.2024 18:15
Episode Notes In this episode, DASON Clinical Pharmacist Liaison Dr. April Dyer walks us through an article from Clinical Infectious Diseases entitled "Beyond Infection: Mortality and End-of-Life Care Associated with Infectious Disease Consultation in an Academic Health System." The article reviewed in this episode can be found here: https://pubmed.ncbi.nlm.nih.gov/38867715/ For more inf...
Ep.90 – It Goes On and On and On: Reviewing the new RCT for Continuous infusion vs. Intermittent infusion Beta-lactams 21.06.2024 31:42
In this exciting episode, Drs. Libby Dodds Ashley and Jeannette Bouchard are joined by Dr. Jason Roberts to discuss his two newly published articles in JAMA that help to answer the question: is there a difference between continuous and intermittent infusions of beta-lactam antibiotics, especially in the critically ill populations? The reviewed materials can be found here: https://dason.medicine.du...
Ep.89 – Infectious Disease Consultations: Can AI Really Replace Human Experts? 07.06.2024 22:01
In this episode of the DASON Digest podcast, DASON Clinical Pharmacist Liaison Dr. Angelina Davis talks to us about the use of AI in the management of bloodstream infections. The article reviewed can be found here: https://academic.oup.com/cid/article-abstract/78/4/825/7308526
Ep.88 – Is the debate back?: A retrospective study in patients with sepsis who received piperacillin-tazobactam vs. cefepime 24.05.2024 17:31
Episode Notes In this episode, Dr. Jeannette Bouchard discusses a newly published article in JAMA about the use of piperacillin-tazobactam and cefepime in sepsis. This episode also ties into a previous episode (#74) and we would recommend listening to both episodes! The article reviewed in this episode can be found here: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2818278 For...
Ep.87 – BCI(De-escalation): The Impact of Rapid Diagnostics and Stewardship Intervention on Treatment of Contaminated Blood Cultures 10.05.2024 23:20
Episode Notes In this episode, University of Kentucky Infectious Diseases Pharmacy Residents, Will Harris and Tyler Pitcock, review a recently published article evaluating the impact of the implementation of rapid blood culture identification technology and stewardship intervention on treatment of blood cultures contaminated with coagulase-negative staphylococci. The article reviewed in this episo...
Ep.86 – PEN-FAST and Furious: The efficacy of the PEN-FAST tool in de-labeling previously reported penicillin allergies 26.04.2024 26:47
Episode Notes In this episode, University of Kentucky PGY2 Infectious Diseases Pharmacy Residents, Will Harris and Tyler Pitcock, discuss the recently published article evaluating the efficacy of the clinical decision tool, PEN-FAST, in de-labeling patients with reported penicillin allergies with one of the authors and Duke University Hospital Infectious Diseases Physicians, Dr. Nick Turner. The a...
Ep.85 – The devil's in the defaults: the impact of eliminating default durations of therapy 12.04.2024 27:04
Episode Notes In this episode, Duke University Hospital Infectious Diseases Pharmacist Dr. Rebekah Wrenn and her resident, Amy Mackowiak, review Dr. Wrenn's recently published article evaluating the impact of default duration elimination on exposure to fluoroquinolone therapy. The article reviewed in today's episode can be found here: https://pubmed.ncbi.nlm.nih.gov/38347810/ For more information...
Ep.84 – Navigating the LAByrinth: Updates in Antibacterial Susceptibility Testing 05.04.2024 53:43
Episode Notes In this episode of the DASON Digest Podcast, one of our DASON Clinical Pharmacist Liaisons, Dr. Melissa Johnson, talks with Dr. Jim Lewis, ID Clinical Pharmacy Coordinator and Adjunct Associate Professor at Oregon Health & Science University Departments of Pharmacy and ID in Portland, Oregon. The material reviewed in today's podcast can be found here: https://clsi.org/standards/p...
Ep.83 – Incorporating Adverse Event Feedback Into Antibiotic Stewardship 15.03.2024 14:34
Episode Notes In this episode of the DASON Digest podcast, DASON Clinical Pharmacist Liaison Dr. April Dyer talks to us about how to incorporate adverse event feedback into antibiotic stewardship. The article reviewed in this episode can be found here: https://pubmed.ncbi.nlm.nih.gov/38415083/ For more information about DASON, please visit: https://dason.medicine.duke.edu
Ep.82 – Optimizing the use of the GI Panel and strategies to improve appropriate testing 01.03.2024 18:45
Episode Notes In this episode, DASON Clinical Pharmacist Liaisons Drs. Jeannette Bouchard and Libby Dodds-Ashley walk us through the details of a recent article published in ASHE to assess the impact of a clinical decision support survey to improve GI Panel ordering appropriateness at a VA. The article reviewed in this episode can be found here: https://pubmed.ncbi.nlm.nih.gov/38415090/ For more i...
Ep.81 – Which of Active vs Passive Response to Rapid Diagnostic Blood Culture Results 19.02.2024 14:22
Episode Notes In this episode of the DASON Digest podcast, DASON Clinical Pharmacist Liaison Dr. Angelina Davis talks to us about the use of active versus passive methods of responding to rapid diagnostic blood culture results. The article reviewed can be found here: https://pubmed.ncbi.nlm.nih.gov/36483427/ For more information about DASON, please visit: https://dason.medicine.duke.edu/
Ep.80 – Exploring the Microbiome: Pertinent details from a phase 1 study exploring omadacycline in healthy guts 02.02.2024 23:34
Episode Notes In this episode, DASON Clinical Pharmacist Liaison Dr. Jeannette Bouchard is joined by Dr. Kevin Garey, an adjunct professor at the University of Texas School of Public Health and senior author of the reviewed article. They walk us through the details of the microbiome effects oral omadacycline has versus oral vancomycin and what this might mean for the future of the treatment for C....
Ep.79 – It’s All in the Dose: High-dose oral beta-lactams for bacteremic UTIs due to Enterobacterales 19.01.2024 19:32
Episode Notes In this episode, DASON Clinical Pharmacist Liaisons Drs. Melissa Johnson and Jeannette Bouchard discuss an article from ASHE on high-dose oral beta-lactam definitive therapy compared to fluoroquinolone or trimethoprim-sulfamethoxazole oral therapy for bacteremia secondary to a urinary tract infection. The article reviewed can be found here: https://pubmed.ncbi.nlm.nih.gov/37771747/ F...
Ep.78 – Source Specific Sepsis Order Sets Lead to Improved Empiric Therapy in the ED 05.01.2024 10:46
Episode Notes In this episode, Dr. April Dyer, one of our DASON Clinical Pharmacist Liaisons, talks to us about source specific order sets leading to improved empiric therapy in the ED in a 200 bed hospital. The article reviewed in this episode can be found here: https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofad677/7491622# To learn more about DASON, please visit: https://dason.m...
Ep.77 – Optimizing Outpatient Ordering 15.12.2023 29:06
Episode Notes In this episode, Drs. Bouchard, Dodds Ashley, and Perez review a large study tackling inappropriate antimicrobial use in the outpatient setting. The article reviewed in this episode can be found here: https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofad585/7439469 For more information about DASON, please visit: https://dason.medicine.duke.edu
Ep.76 – Ending VAP: is vaporizing antibiotics the answer? 01.12.2023 20:06
Episode Notes In this episode, Drs. Libby Dodds Ashley and Jeannette Bouchard, two of our DASON Clinical Pharmacists, talk to us about bringing and end to VAP. The article reviewed in this episode can be found here: https://pubmed.ncbi.nlm.nih.gov/37888914/ For more information about DASON, please visit: https://dason.medicine.duke.edu
Ep.75 – Febrile Podcast: Being a Stewie 20.11.2023 45:07
Episode Notes This week we would like to use the feed to share a great episode of Sara Dong's podcast "Febrile." Members of our DASON team and the Society for Healthcare Epidemiology of America's antimicrobial stewardship committee celebrate antibiotic awareness week by discussing stewardship teams and an example case.
Ep.74 – Neurotoxicity vs Nephrotoxicity: A Look at the Comparative Safety of Cefepime and Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection 03.11.2023 21:03
Episode Notes In this episode, Dr. April Dyer, one of the DASON Clinical Pharmacists, talks about cefepime vs piperacillin-tazobactam in adults hospitalized with acute infection. The article reviewed in this episode can be found here: https://pubmed.ncbi.nlm.nih.gov/37837651/ For more information about DASON, please visit: https://dason.medicine.duke.edu
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.